Bank of America Corporation (BAC), with a market capitalization of $387.9 billion, is preparing to release its fiscal Q3 2026 earnings before the market opens on Wednesday, October 14. The company operates through four main segments: Consumer Banking, Global Wealth & Investment Management, Global Banking, and Global Markets, serving a diverse clientele including individuals, small and mid-sized businesses, large corporations, and governments worldwide.

Read More

Analysts anticipate that Bank of America will report earnings of $1.17 per share for the quarter, a 10.4% increase from $1.06 in the same quarter last year. The company has consistently exceeded Wall Street's earnings estimates for the past four quarters.

For the entire fiscal year 2026, projections indicate an adjusted EPS of $4.66, reflecting a 22.3% rise from $3.81 in fiscal 2025. Over the past year, Bank of America's stock price has increased by 5.8%, although this growth is below the 15.3% gain of the S&P 500 Index during the same timeframe. In comparison, it has slightly outperformed the State Street Financial Select Sector SPDR ETF’s (XLF) returns.

On July 14, Bank of America's shares saw a 1.9% increase following its Q2 2026 report, which showcased a net income of $9.1 billion or $1.21 per share. This growth was attributed to record trading performance, including a 33% rise in sales and trading revenue to $7.1 billion, a 70% jump in equities revenue to $3.6 billion, and a 50% increase in investment banking fees to $2.1 billion due to robust deal activity. The company has also expressed increased confidence in its outlook, expecting net interest income growth for the full year 2026 to reach the upper end of its forecast range of 6% to 8%, following a 9% year-over-year growth to $16 billion in Q2.

Currently, analysts maintain a cautiously optimistic view of BAC stock, with an overall "Moderate Buy" rating. Of the 25 analysts monitoring the stock, 15 recommend a "Strong Buy," four advocate for a "Moderate Buy," and six suggest a "Hold." The average analyst price target stands at $66.62, which is 20.4% above its current level.